RxDoctor Payments DataLook up a doctor →

Donna Ryan

Internal Medicine · Baton Rouge, LANPI 1801197363

Payments from drug & device makers

$991,214in general payments, 2019–2025

Across 789 payments — averaging $1256.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$431K
  • Lilly USA, LLC$174K
  • Novo Nordisk AS$101K
  • Eli Lilly$79K
  • Boehringer Ingelheim$64K
  • Bausch Health US, LLC$29K
  • plus $114K from 17 others
$99,637in research payments, 2019–2025

Across 48 payments — averaging $2075.78 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Novo Nordisk AS$89K
  • Amgen$11K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$991,214 in reported general payments places this provider in the 95th percentile of 1,528 internal medicine providers in Louisiana.

See all internal medicine providers in Louisiana

Other internal medicine in Baton Rouge

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →